Ajanta Pharma Limited (AJANTPHARM) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Ajanta Pharma Limited (AJANTPHARM) has a cash flow conversion efficiency ratio of 0.066x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs2.84 Billion ≈ $30.71 Million USD) by net assets (Rs43.15 Billion ≈ $466.65 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see AJANTPHARM market cap for the company's overall valuation and market capitalisation.
Ajanta Pharma Limited - Cash Flow Conversion Efficiency Trend (2005–2025)
This chart illustrates how Ajanta Pharma Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Ajanta Pharma Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Ajanta Pharma Limited ranked by their cash flow conversion efficiency. Explore Ajanta Pharma Limited (AJANTPHARM) cash earnings ratio to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Crocs Inc
NASDAQ:CROX
|
-0.037x |
|
Celanese Corporation
NYSE:CE
|
0.062x |
|
Fujian Wanchen Biotechnology Co. Ltd
SHE:300972
|
N/A |
|
Nexstar Broadcasting Group Inc
NASDAQ:NXST
|
0.133x |
|
SIG Combibloc Group AG
SW:SIGN
|
0.185x |
|
Guangzhou Shiyuan Electronic Technology Co Ltd
SHE:002841
|
-0.024x |
|
TAL Education Group
NYSE:TAL
|
0.117x |
|
KEI Industries Limited
NSE:KEI
|
0.062x |
Annual Cash Flow Conversion Efficiency for Ajanta Pharma Limited (2005–2025)
The table below shows the annual cash flow conversion efficiency of Ajanta Pharma Limited from 2005 to 2025. View AJANTPHARM stock price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-03-31 | Rs37.90 Billion ≈ $409.91 Million |
Rs11.57 Billion ≈ $125.15 Million |
0.305x | +38.73% |
| 2024-03-31 | Rs35.67 Billion ≈ $385.80 Million |
Rs7.85 Billion ≈ $84.90 Million |
0.220x | -5.83% |
| 2023-03-31 | Rs33.88 Billion ≈ $366.40 Million |
Rs7.92 Billion ≈ $85.63 Million |
0.234x | +35.73% |
| 2022-03-31 | Rs32.64 Billion ≈ $353.03 Million |
Rs5.62 Billion ≈ $60.78 Million |
0.172x | -10.50% |
| 2021-03-31 | Rs29.96 Billion ≈ $323.97 Million |
Rs5.76 Billion ≈ $62.33 Million |
0.192x | +9.46% |
| 2020-03-31 | Rs25.99 Billion ≈ $281.06 Million |
Rs4.57 Billion ≈ $49.40 Million |
0.176x | +5.29% |
| 2019-03-31 | Rs22.45 Billion ≈ $242.81 Million |
Rs3.75 Billion ≈ $40.53 Million |
0.167x | +19.39% |
| 2018-03-31 | Rs20.41 Billion ≈ $220.77 Million |
Rs2.85 Billion ≈ $30.87 Million |
0.140x | -63.95% |
| 2017-03-31 | Rs15.68 Billion ≈ $169.54 Million |
Rs6.08 Billion ≈ $65.76 Million |
0.388x | +39.29% |
| 2016-03-31 | Rs11.72 Billion ≈ $126.75 Million |
Rs3.26 Billion ≈ $35.30 Million |
0.278x | -16.18% |
| 2015-03-31 | Rs8.41 Billion ≈ $90.96 Million |
Rs2.79 Billion ≈ $30.22 Million |
0.332x | -7.21% |
| 2014-03-31 | Rs5.93 Billion ≈ $64.16 Million |
Rs2.12 Billion ≈ $22.97 Million |
0.358x | -40.32% |
| 2013-03-31 | Rs3.93 Billion ≈ $42.51 Million |
Rs2.36 Billion ≈ $25.50 Million |
0.600x | +133.59% |
| 2012-03-31 | Rs2.98 Billion ≈ $32.23 Million |
Rs765.41 Million ≈ $8.28 Million |
0.257x | -41.57% |
| 2011-03-31 | Rs2.29 Billion ≈ $24.75 Million |
Rs1.01 Billion ≈ $10.88 Million |
0.440x | -14.54% |
| 2010-03-31 | Rs1.85 Billion ≈ $20.00 Million |
Rs951.16 Million ≈ $10.29 Million |
0.514x | +133.60% |
| 2009-03-31 | Rs1.57 Billion ≈ $16.99 Million |
Rs345.92 Million ≈ $3.74 Million |
0.220x | +55.96% |
| 2008-03-31 | Rs1.35 Billion ≈ $14.62 Million |
Rs190.81 Million ≈ $2.06 Million |
0.141x | -22.80% |
| 2007-03-31 | Rs1.16 Billion ≈ $12.50 Million |
Rs211.30 Million ≈ $2.29 Million |
0.183x | -21.67% |
| 2006-03-31 | Rs1.09 Billion ≈ $11.74 Million |
Rs253.45 Million ≈ $2.74 Million |
0.233x | +446.42% |
| 2005-03-31 | Rs978.24 Million ≈ $10.58 Million |
Rs-65.93 Million ≈ $-713.01K |
-0.067x | -- |
About Ajanta Pharma Limited
Ajanta Pharma Limited, together with its subsidiaries, a pharmaceutical formulation company that develops, manufactures, and markets specialty pharmaceutical finished dosages. The company offers chronic and acute therapies; branded generic products; and a range of dosage forms, including tablets, capsules, injectables, inhalers, ointments, creams, and liquids. It also serves various therapeutic a… Read more